Given the enormous heterogeneity in the manifestations of the core features of ASD [3], genetic mutations in related diseases, such as mutations in SHANK2 and SHANK3 in autism, MECP2 in Rett’s syndrome, and FMR1 in fragile X syndrome, have become the focus of studies [4–7]. This evidence concerns the gene SHANK3 and autism.